Dr. Lacy’s role on the biomedical company’s board includes advising Biomerica on the commercialization of Biomerica InFoods Technology platform products such as its irritable bowel syndrome product, according to a Jan. 10 news release.
Dr. Lacy has written more than 225 peer-reviewed articles and was the former co-editor-in-chief of the American Journal of Gastroenterology.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
